IATF approves COVID-19 clinical trials on pediatric age group

Clinical trials focused on fighting emerging variants of the COVID-19 virus might start soon, Malacañang announced on Saturday (Sept. 4).

The Inter-Agency Task Force (IATF), subject to the considerations of the Food and Drug Administration (FDA), approved the recommendation for sponsors or trialists.

The IATF plans to shift its focus towards people of different age groups and people with comorbidities, or the immunocompromised, to be more inclusive in addressing the COVID-19 pandemic, Presidential Spokesperson Harry Roque said in a statement.

The recommendation to prioritize Phase three clinical trials that will focus on the pediatric age group of six months to 12 years old was approved by the IATF last Sept.4.

The Phase three clinical trials will also include the elderly (more than 60 years old), pregnant mothers, patients with immunodeficiency, patients with autoimmune diseases, patients with renal diseases, and patients with chronic respiratory diseases. – PG – bny

Popular

SSS to roll out 3-year pension hike starting September 2025

By Anna Leah Gonzales | Philippine News Agency State-run Social Security System (SSS) said it will implement a Pension Reform Program, which features a structured,...

DOE to talk with DSWD, DILG for Lifeline Rate utilization

By Joann Villanueva | Philippine News Agency The Department of Energy (DOE) is set to discuss with other government agencies the inclusion of more Pantawid...

Zero-billing for basic accommodation in DOH hospitals applicable to everyone —Herbosa

By Brian Campued The “zero balance billing” being implemented in all Department of Health (DOH)-run hospitals across the country is applicable to everyone as long...

DepEd committed to address classroom shortage

By Brian Campued Department of Education (DepEd) Secretary Sonny Angara on Wednesday emphasized the importance of Public-Private Partnerships (PPPs) in addressing the shortage of classrooms...